Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
L-methionine + nicotinamide
L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
nicotinamide + S-adenosyl-L-methionine
1-methylnicotinamide + S-adenosyl-L-homocysteine
S-adenosyl-L-methionine + 1,2,3,4-tetrahydroisoquinoline
S-adenosyl-L-homocysteine + ?
-
-
-
-
?
S-adenosyl-L-methionine + 2-methoxypyridine
S-adenosyl-L-homocysteine + 1-methyl-2-methoxypyridinium
-
-
-
?
S-adenosyl-L-methionine + 2-methylpyridine
S-adenosyl-L-homocysteine + 1,2-dimethylpyridinium
-
-
-
?
S-adenosyl-L-methionine + 3-acetylpyridine
S-adenosyl-L-homocysteine + ?
-
-
-
-
?
S-adenosyl-L-methionine + 3-acetylpyridine
S-adenosyl-L-homocysteine + N-methyl-3-acetylpyridinium
-
-
-
?
S-adenosyl-L-methionine + 4-methylnicotinamide
S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide
S-adenosyl-L-methionine + 4-phenylpyridine
S-adenosyl-L-homocysteine + 1-methyl-4-phenylpyridine
poor substrate
-
-
?
S-adenosyl-L-methionine + isoquinoline
S-adenosyl-L-homocysteine + ?
-
-
-
-
?
S-adenosyl-L-methionine + isoquinoline
S-adenosyl-L-homocysteine + N-methylisoquinoline
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
S-adenosyl-L-methionine + nicotinimidamide
S-adenosyl-L-homocysteine + N-methylnicotinimidamide
-
-
-
?
S-adenosyl-L-methionine + norharman + H+
S-adenosyl-L-homocysteine + 2-N-methylnorharman
-
-
-
?
S-adenosyl-L-methionine + quinoline
S-adenosyl-L-homocysteine + ?
-
-
-
-
?
S-adenosyl-L-methionine + quinoline
S-adenosyl-L-homocysteine + N-methylquinoline
S-adenosyl-L-methionine + quinoline 3-carboxamide
S-adenosyl-L-homocysteine + N-methylquinoline 3-carboxamide
-
-
-
?
S-adenosyl-L-methionine + tetrahydroisoquinoline
S-adenosyl-L-homocysteine + N-methyltetrahydroisoquinoline
-
-
-
?
S-adenosyl-L-methionine + thionicotinamide
S-adenosyl-L-homocysteine + 1-methylthionicotinamide
additional information
?
-
nicotinamide + S-adenosyl-L-methionine

1-methylnicotinamide + S-adenosyl-L-homocysteine
-
-
-
-
?
nicotinamide + S-adenosyl-L-methionine
1-methylnicotinamide + S-adenosyl-L-homocysteine
-
-
-
?
S-adenosyl-L-methionine + 4-methylnicotinamide

S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide
-
-
-
?
S-adenosyl-L-methionine + 4-methylnicotinamide
S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide
-
assay for fluorometric determination of enzyme activity
-
-
?
S-adenosyl-L-methionine + 4-methylnicotinamide
S-adenosyl-L-homocysteine + 1,4-dimethylnicotinamide
-
assay for fluorometric determination of enzyme activity
-
-
?
S-adenosyl-L-methionine + nicotinamide

S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
441253, 441255, 701990, 733214, 733279, 733614, 733618, 733625, 733636, 734104, 734368 -
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
NNMT as potential candidate for a tumor marker
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
NNMT gene polymorphism as potential marker for cardiovascular risk factors
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
NNMT potential as tumor marker
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
polymorphism in the nicotinamide N-methyltransferase (NNMT) gene as risk factor for complex congenital heart defects (CHDs)
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
L-methionine + nicotinamide
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + quinoline

S-adenosyl-L-homocysteine + N-methylquinoline
-
-
-
?
S-adenosyl-L-methionine + quinoline
S-adenosyl-L-homocysteine + N-methylquinoline
-
-
-
-
?
S-adenosyl-L-methionine + thionicotinamide

S-adenosyl-L-homocysteine + 1-methylthionicotinamide
-
-
-
?
S-adenosyl-L-methionine + thionicotinamide
S-adenosyl-L-homocysteine + 1-methylthionicotinamide
-
-
-
-
?
additional information

?
-
-
NNMT catalyzes the N-methylation of nicotinamide and other structural analogs, and is involved in the biotransformation of many drugs and xenobiotic compounds
-
-
?
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
NNMT uses a rapid equilibrium ordered mechanism, where NNMT first binds S-adenosyl-L-methionine, which is followed by nicotinamide. Methyl transfer occurs, and methylated nicotinamide and S-adenosylhomocysteine are released consecutively
-
-
-
additional information
?
-
-
NNMT uses a rapid equilibrium ordered mechanism, where NNMT first binds S-adenosyl-L-methionine, which is followed by nicotinamide. Methyl transfer occurs, and methylated nicotinamide and S-adenosylhomocysteine are released consecutively
-
-
-
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
-
enzyme may function in detoxificating of numerous alkaloids
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
L-methionine + nicotinamide
L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
additional information
?
-
S-adenosyl-L-methionine + nicotinamide

S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
S-adenosyl-L-methionine + nicotinamide
S-adenosyl-L-homocysteine + 1-methylnicotinamide
-
-
-
-
?
additional information

?
-
-
NNMT catalyzes the N-methylation of nicotinamide and other structural analogs, and is involved in the biotransformation of many drugs and xenobiotic compounds
-
-
?
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
-
development and evaluation of a HPLC-UV method for measuring nicotinamide N-methyltransferase activity in biological samples, overview
-
-
?
additional information
?
-
-
enzyme may function in detoxificating of numerous alkaloids
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1,3-dimethylquinolin-1-ium
-
1,4-dimethylquinolin-1-ium
-
1,5-dimethylquinolin-1-ium
-
1,8-dimethylquinolin-1-ium
-
1-ethyl-4-methylquinolin-1-ium
-
1-ethyl-6-fluoro-4-methylquinolin-1-ium
-
1-ethyl-8-methylquinolin-1-ium
-
1-methyl-3-(methylamino)quinolin-1-ium
-
2-amino-1-methylquinolin-1-ium
-
3-(6-amino-6-oxohexyl)benzamide
inhibitor mimics the transition state of the methylation reaction
3-amino-1-methylquinolin-1-ium
-
3-amino-2-methylisoquinolin-2-ium
-
-
3-amino-6-fluoro-1-methylquinolin-1-ium
-
4-methyl-N'-methylnicotinamide
-
5'-([(3S)-3-amino-3-carboxypropyl][[3-(methoxycarbonyl)phenyl]methyl]amino)-5'-deoxyadenosine
-
5'-deoxy-5'-[[(3S)-3,4-diamino-4-oxobutyl][(naphthalen-2-yl)methyl]amino]adenosine
inhibitor demonstrates a dose-dependent inhibitory effect on the cell proliferation of the HSC-2 human oral cancer cell line
5'-deoxy-5'-[[(naphthalen-2-yl)methyl](propan-2-yl)amino]adenosine
-
5'-[(3-amino-3-carboxypropyl)[3-(3-carbamoyl-4-methylphenyl)prop-2-yn-1-yl]amino]-5'-deoxyadenosine
-
5'-[(3-amino-3-carboxypropyl)[3-(3-carbamoylphenyl)prop-2-yn-1-yl]amino]-5'-deoxyadenosine
compound exhibits around 1000fold selectivity for NNMT over other methyltransferases and almost 100fold selectivity for S-5'-adenosyl-L-homocysteine hydrolase
5'-[(3-amino-3-carboxypropyl)[3-(5-carbamoyl-2-methoxyphenyl)prop-2-yn-1-yl]amino]-5'-deoxyadenosine
-
5'-[(4-amino-4-oxobutyl)[(naphthalen-2-yl)methyl]amino]-5'-deoxyadenosine
-
5'-[(5-amino-5-oxopentyl)[(naphthalen-2-yl)methyl]amino]-5'-deoxyadenosine
-
5'-[[(3S)-3-amino-3-carboxypropyl][(3-carbamoylphenyl)methyl]amino]-5'-deoxyadenosine
5'-[[(3S)-3-amino-3-carboxypropyl][(3-carboxyphenyl)methyl]amino]-5'-deoxyadenosine
-
5'-[[(3S)-3-amino-3-carboxypropyl][4-(3-carbamoylphenyl)butyl]amino]-5'-deoxyadenosine
-
5-amino-1-methylquinolin-1-ium
-
5-[[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-7-(3-carbamoylphenyl)hept-6-ynoic acid
log Ki value 4.65
6-(methylamino)pyridine-3-carboxamide
compound inhibits NNMT enzymatic activity and reduces the formation of 1-methyl-nicotinamide by about 80% at 2 h when dosed in mice orally at 50 mg/kg
6-fluoro-1-methylquinolin-1-ium
-
6-methoxy-4-methylpyridine-3-carboxamide
-
7-(3-carbamoylphenyl)hept-6-ynoic acid
inhibitor mimics the transition state of the methylation reaction
7-amino-1-methylquinolin-1-ium
-
9-(9-amino-5,6,7,8,9-pentadeoxy-6-ethynyl-beta-D-ribo-decofuranuronosyl)-9H-purin-6-amine
log Ki value 4.32
9-[9-amino-6-[(2-carbamoylphenyl)ethynyl]-5,6,7,8,9-pentadeoxy-beta-D-ribo-decofuranuronosyl]-9H-purin-6-amine
log Ki value 4.71
9-[9-amino-6-[(3-carbamoylphenyl)ethynyl]-5,6,7,8,9-pentadeoxy-beta-D-ribo-decofuranuronosyl]-9H-purin-6-amine
high-affinity, subnanomolar NNMT inhibitor
Dimethylsulfoxide
competitive, about 82% inhibition at 1% v/v
Nickel
exposure of BEAS-2B cells to induces NNMT repression at both the protein and mRNA levels
S-adenosyl-L-homocysteine
additional information
-
not inhibitory: Ca2+, SKF 525A, 3,4-dimethoxy-5-hydroxybenzoic acid
-
1-methyl nicotinamide

feedback inhibitor
1-methyl nicotinamide
feedback inhibitor
1-methylnicotinamide

product inhibition
1-methylnicotinamide
-
product inhibition
5'-[[(3S)-3-amino-3-carboxypropyl][(3-carbamoylphenyl)methyl]amino]-5'-deoxyadenosine

bisubstrate inhibitor, competitive with respect to S-adenosyl-L-methionine, noncompetitive with respect to nicotinamide
5'-[[(3S)-3-amino-3-carboxypropyl][(3-carbamoylphenyl)methyl]amino]-5'-deoxyadenosine
inhibitor mimics the transition state of the methylation reaction
Clofibrate

-
inhibits the enzyme in liver micorosomes
Clofibrate
-
inhibits the enzyme in liver microsomes
N1-methylnicotinamide

-
-
N1-methylnicotinamide
-
IC50 0.06 mM for human protein, 0.03 mM for recombinant protein
nicotinamide

-
the enzyme shows substrate inhibition kinetics
nicotinamide
-
the enzyme shows substrate inhibition kinetics
nicotinamide
-
the enzyme shows substrate inhibition kinetics
S-adenosyl-L-homocysteine

-
-
S-adenosyl-L-homocysteine
product inhibition
S-adenosyl-L-homocysteine
-
S-adenosyl-L-homocysteine
-
-
sinefungin

-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.2
1,2,3,4-tetrahydroisoquinoline
-
-
0.548
2-methoxypyridine
pH 8.6, 37°C
2.029
2-methylpyridine
pH 8.6, 37°C
0.727
3-acetylpyridine
pH 8.6, 37°C
0.335
4-methylnicotinamide
pH 8.6, 37°C
0.125
4-phenylpyridine
pH not specified in the publication, temperature not specified in the publication
0.003 - 11.8
nicotinamide
1.326
nicotinimidamide
pH 8.6, 37°C
0.09
norharman
pH 8.6, 37°C
0.364
quinoline 3-carboxamide
pH 8.6, 37°C
0.00176 - 3.5
S-adenosyl-L-methionine
0.613
tetrahydroisoquinoline
pH 8.6, 37°C
0.111
Thionicotinamide
pH 8.6, 37°C
additional information
additional information
-
0.087
Isoquinoline

pH 8.6, 37°C
0.003
nicotinamide

pH 8.6, 37°C
0.02
nicotinamide
pH 7.5, temperature not specified in the publication
0.105
nicotinamide
K100A/E101A/E103A mutant protein, pH 8.6, 37°C
0.199
nicotinamide
pH 8.6, 37°C
0.24
nicotinamide
Y20F mutant protein, pH 8.6, 37°C
0.38
nicotinamide
-
recombinant protein
0.4
nicotinamide
0.43-0.38 mM, wild type protein, pH 8.6, 37°C
0.63
nicotinamide
Y20A mutant protein, pH 8.6, 37°C
1.02
nicotinamide
-
pH 7.2, 37°C, liver homogenate
1.36
nicotinamide
-
pH 7.2, 37°C, liver homogenate
11.8
nicotinamide
D197A mutant protein, pH 8.6, 37°C
0.01
Quinoline

pH 8.6, 37°C
0.609
Quinoline
pH 8.6, 37°C
0.00176
S-adenosyl-L-methionine

-
-
0.0018
S-adenosyl-L-methionine
-
-
0.002
S-adenosyl-L-methionine
0.0018-0.0022 mM, wild type protein, pH 8.6, 37°C
0.0022
S-adenosyl-L-methionine
-
recombinant protein
0.005
S-adenosyl-L-methionine
K100A/E101A/E103A mutant protein, pH 8.6, 37°C
0.0065
S-adenosyl-L-methionine
-
-
0.0085
S-adenosyl-L-methionine
pH 8.6, 37°C
0.01
S-adenosyl-L-methionine
pH 8.6, 37°C
0.016
S-adenosyl-L-methionine
-
-
0.024
S-adenosyl-L-methionine
pH 7.5, temperature not specified in the publication
0.028
S-adenosyl-L-methionine
Y20F mutant protein, pH 8.6, 37°C
2.73
S-adenosyl-L-methionine
D197A mutant protein, pH 8.6, 37°C
3.5
S-adenosyl-L-methionine
Y20A mutant protein, pH 8.6, 37°C
additional information
additional information

-
Michaelis-Menten kinetics
-
additional information
additional information
-
Michaelis-Menten kinetics
-
additional information
additional information
-
Michaelis-Menten kinetics, the Km value cannot be determined using Michaelis-Menten kinetic modelling
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.